276 related articles for article (PubMed ID: 15753661)
21. Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
Raben D; Bianco C; Damiano V; Bianco R; Melisi D; Mignogna C; D'Armiento FP; Cionini L; Bianco AR; Tortora G; Ciardiello F; Bunn P
Mol Cancer Ther; 2004 Aug; 3(8):977-83. PubMed ID: 15299080
[TBL] [Abstract][Full Text] [Related]
22. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells.
Shieh JJ; Liu KT; Huang SW; Chen YJ; Hsieh TY
J Invest Dermatol; 2009 Oct; 129(10):2497-506. PubMed ID: 19369967
[TBL] [Abstract][Full Text] [Related]
23. Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3.
Zannetti A; Iommelli F; Fonti R; Papaccioli A; Sommella J; Lettieri A; Pirozzi G; Bianco R; Tortora G; Salvatore M; Del Vecchio S
Clin Cancer Res; 2008 Aug; 14(16):5209-19. PubMed ID: 18698039
[TBL] [Abstract][Full Text] [Related]
24. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
[TBL] [Abstract][Full Text] [Related]
25. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils.
Epling-Burnette PK; Zhong B; Bai F; Jiang K; Bailey RD; Garcia R; Jove R; Djeu JY; Loughran TP; Wei S
J Immunol; 2001 Jun; 166(12):7486-95. PubMed ID: 11390502
[TBL] [Abstract][Full Text] [Related]
26. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B
J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138
[TBL] [Abstract][Full Text] [Related]
27. Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: role of Nur77 and Bcl-2.
Kfir S; Sionov RV; Zafrir E; Zilberman Y; Yefenof E
Cell Cycle; 2007 Dec; 6(24):3086-96. PubMed ID: 18073527
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
[TBL] [Abstract][Full Text] [Related]
29. ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells.
Ciardiello F; Caputo R; Borriello G; Del Bufalo D; Biroccio A; Zupi G; Bianco AR; Tortora G
Int J Cancer; 2002 Mar; 98(3):463-9. PubMed ID: 11920601
[TBL] [Abstract][Full Text] [Related]
30. Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation.
Das AK; Sato M; Story MD; Peyton M; Graves R; Redpath S; Girard L; Gazdar AF; Shay JW; Minna JD; Nirodi CS
Cancer Res; 2006 Oct; 66(19):9601-8. PubMed ID: 17018617
[TBL] [Abstract][Full Text] [Related]
31. Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage.
Yuan BZ; Chapman J; Reynolds SH
Oncogene; 2009 Oct; 28(43):3775-86. PubMed ID: 19684616
[TBL] [Abstract][Full Text] [Related]
32. Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells.
Wacheck V; Cejka D; Sieghart W; Losert D; Strommer S; Crevenna R; Monia BP; Selzer E
Cancer Biol Ther; 2006 Oct; 5(10):1348-54. PubMed ID: 16969094
[TBL] [Abstract][Full Text] [Related]
33. Myeloid cell factor-1 is a critical survival factor for multiple myeloma.
Zhang B; Gojo I; Fenton RG
Blood; 2002 Mar; 99(6):1885-93. PubMed ID: 11877256
[TBL] [Abstract][Full Text] [Related]
34. Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.
Busser B; Sancey L; Josserand V; Niang C; Khochbin S; Favrot MC; Coll JL; Hurbin A
Mol Ther; 2010 Mar; 18(3):536-43. PubMed ID: 19826407
[TBL] [Abstract][Full Text] [Related]
35. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.
Kaufmann SH; Karp JE; Svingen PA; Krajewski S; Burke PJ; Gore SD; Reed JC
Blood; 1998 Feb; 91(3):991-1000. PubMed ID: 9446661
[TBL] [Abstract][Full Text] [Related]
36. Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
Ma Y; Cress WD; Haura EB
Mol Cancer Ther; 2003 Jan; 2(1):73-81. PubMed ID: 12533675
[TBL] [Abstract][Full Text] [Related]
37. Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Valko Z; Megyesfalvi Z; Schwendenwein A; Lang C; Paku S; Barany N; Ferencz B; Horvath-Rozsas A; Kovacs I; Schlegl E; Pozonec V; Boettiger K; Rezeli M; Marko-Varga G; Renyi-Vamos F; Hoda MA; Klikovits T; Hoetzenecker K; Grusch M; Laszlo V; Dome B; Schelch K
Br J Cancer; 2023 May; 128(10):1850-1861. PubMed ID: 36918717
[TBL] [Abstract][Full Text] [Related]
38. The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis.
Sitailo LA; Tibudan SS; Denning MF
J Biol Chem; 2006 Oct; 281(40):29703-10. PubMed ID: 16901898
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of Mcl-1 with antisense technology alters the effect of various cytotoxic agents used in treatment of squamous cell carcinoma of the head and neck.
Skoda C; Erovic BM; Wachek V; Vormittag L; Wrba F; Martinek H; Heiduschka G; Kloimstein P; Selzer E; Thurnher D
Oncol Rep; 2008 Jun; 19(6):1499-503. PubMed ID: 18497956
[TBL] [Abstract][Full Text] [Related]
40. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions.
Zhou P; Qian L; Kozopas KM; Craig RW
Blood; 1997 Jan; 89(2):630-43. PubMed ID: 9002967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
